Lucy Pérez is a senior partner in McKinsey & Company’s Boston office. A former cancer researcher, Lucy brings a strong technical background to her work with organizations across the life-sciences sector. Since joining McKinsey, she has partnered with CEOs and top teams at leading organizations across North America, Europe, and Asia. She leads evidence-generation work within the Life Sciences Practice, helping clients generate and apply research insights, clinical data, and real-world evidence to maximize patient benefit, demonstrate product value, and catalyze innovation. In addition to her client service, Lucy coleads the North America Hispanic Latino Network, a platform for consultants and Hispanic and Latino leaders to connect and build community as well as advance their professional development. Before joining McKinsey, Lucy was a research fellow at Memorial Sloan Kettering Cancer Center. She was also a Howard Hughes Medical Institute research fellow at Harvard University while completing her doctoral studies.
Shubham Singhal is a senior partner in Detroit. Shubham leads McKinsey’s healthcare, public sector and social sector work globally. He serves leading healthcare and social institutions and governments on all top-management agenda issues. His primary areas of focus include strategy, growth, M&A, business building, and large-scale digital and performance transformations. In healthcare, he has extensively served publicly traded and not-for-profit payers as well as public payers for more than 20 years. He also serves providers as well as healthcare technology and pharmacy companies. Shubham also leads the firm’s thinking and research on the future of healthcare in the wake of rapid advancements in digital, advanced analytics, and medical technologies; emergence of new treatments; healthcare reform and regulatory change; the rise of the healthcare consumer; and risk disaggregation and reallocation across the healthcare system.
Funding in FemTech startups has risen from next to nothing in 2008, to almost $2.5 billion in 2021; deals have seen the same trend, from a handful to almost 300 over the same period.